Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Espoir pour la Santé (EPLS) is a prominent biomedical research center based in Saint-Louis, Senegal, dedicated to combating infectious and parasitic diseases in West Africa. Established in 1990, the center specializes in clinical trials, epidemiological surveillance, and immunological research, with a primary focus on malaria, schistosomiasis, and tuberculosis. EPLS operates high-standard laboratory facilities and collaborates extensively with international academic institutions and global health organizations to evaluate new vaccines and therapeutic interventions. The organization is well-known for its pivotal role in conducting Phase 1 through Phase 3 clinical trials for neglected tropical diseases. Its mission combines advanced scientific research with community-based health programs to improve public health outcomes in the Senegal River basin and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomedical Research Center ESPOIR POUR LA SANTE.